Atovaquone is used to treat or prevent pneumocystis pneumonia, toxoplasmosis, malaria and babesiosis. Atovaquone inhibits the cytochrome bc(1) complex via interactions with the Rieske iron-sulfur protein and cytochrome b in the ubiquinol oxidation pocket. In addition to its use as a treatment for toxoplasmosis, atovaquone has antimalarial properties and prevents pneumocystis pneumonia post-renal transplant.
|Package details:||10g/PE bottle;1kg/foil bag|
It is indicated for oral treatment of AIDS patients with mild to moderate Carne's pneumonia who cannot tolerate SMZ-TMP.
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!